CB1 Capital Management predicts Cannabis could disrupt the healthcare industry in a big way. The firm's Founding Partner and Chief Investment Officer Todd Harrison explains why he thinks medical marijuana will migrate from state dispensaries, to become medicine prescribed by doctors through insurance in the next decade.
Harrison says the only way the U.S. government would get their hands on the money in this market opportunity is through the FDA. "That's where we think it goes, follow the money," says Harrison.
"This is not so much a trade about commerce, as it is a trade about healthcare," said Harrison. "We think that this is going to migrate towards medicine." One of CB1 Capital Management's holdings GW Pharmaceuticals is up 30 percent over the past three months. Harrison expects this company to publish research showing the efficacy of cannabis treatment this summer.
The major indices reached all-time highs this week – but when it comes to that Dow Jones record, veteran CIO Kevin Mahn says, ‘I don’t even look at the Dow.’
The WNBA is gearing up for what is sure to be an incredible season — with sold out crowds and high ratings. It's Caitlin's world, we're just living in it.
Tipping expectations have increased. A 2023 survey revealed that approximately 72% feel they are now asked to tip service workers more often than before.
Inflation-weary Americans are still spending money every month, but the April numbers show they’re starting to cut back on a few types of expensive purchases.
